We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
-3.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.41B
AUM Growth
+$279M
Cap. Flow
+$377M
Cap. Flow %
26.74%
Top 10 Hldgs %
7.59%
Holding
877
New
177
Increased
293
Reduced
202
Closed
151

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$7.53M
2
FRPT icon
Freshpet
FRPT
+$6.94M
3
S icon
SentinelOne
S
+$6.3M
4
ANET icon
Arista Networks
ANET
+$6.03M
5
CVNA icon
Carvana
CVNA
+$5.95M

Top Sells

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$6.92M
2
F icon
Ford
F
+$6.05M
3
BIIB icon
Biogen
BIIB
+$6.03M
4
AKRO
Akero Therapeutics
AKRO
+$5.18M
5
RL icon
Ralph Lauren
RL
+$4.73M

Sector Composition

Rank Sector Weight
1 Technology 23.24%
2 Healthcare 19.71%
3 Consumer Discretionary 12.99%
4 Industrials 11.27%
5 Financials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VCEL icon
226
Vericel Corp
VCEL
$2.38B
$2.2M 0.16%
49,325
+14,618
+42% +$787K
DNA icon
227
Ginkgo Bioworks
DNA
$498M
$2.2M 0.16%
385,153
+196,350
+104% +$2M
LTH icon
228
Life Time Group Holdings
LTH
$10.2B
$2.2M 0.16%
72,687
– –
LEVI icon
229
Levi Strauss
LEVI
$9.49B
$2.19M 0.16%
140,373
+43,659
+45% +$760K
JAMF
230
DELISTED
Jamf
JAMF
$2.19M 0.16%
180,030
+166,953
+1,277% +$2.39M
KEX icon
231
Kirby Corp
KEX
$7.01B
$2.18M 0.16%
+21,608
New +$2.26M
EQT icon
232
EQT Corp
EQT
$32.9B
$2.17M 0.15%
+40,600
New +$2.07M
RPRX icon
233
Royalty Pharma
RPRX
$26.2B
$2.17M 0.15%
69,633
+100
+0.1% +$3.17K
OKTA icon
234
Okta
OKTA
$23.8B
$2.17M 0.15%
+20,600
New +$2.01M
GPGI
235
GPGI Inc
GPGI
$3.87B
$2.16M 0.15%
+198,394
New +$2.43M
DDOG icon
236
Datadog
DDOG
$94B
$2.15M 0.15%
+21,700
New +$2.74M
ATRO icon
237
Astronics
ATRO
$3.21B
$2.15M 0.15%
106,542
+30,244
+40% +$508K
INDV icon
238
Indivior Pharmaceuticals
INDV
$4.74B
$2.15M 0.15%
225,115
+167,595
+291% +$1.76M
PAYO icon
239
Payoneer
PAYO
$2.41B
$2.11M 0.15%
288,928
-140,369
-33% -$1.31M
PCOR icon
240
Procore
PCOR
$7.57B
$2.11M 0.15%
+31,954
New +$2.41M
BMI icon
241
Badger Meter
BMI
$3.87B
$2.1M 0.15%
11,036
-5,572
-34% -$1.16M
VFC icon
242
VF Corp
VFC
$5.92B
$2.09M 0.15%
134,797
-146,292
-52% -$3.24M
OGS icon
243
ONE Gas
OGS
$5.01B
$2.07M 0.15%
27,448
+1
+0% +$72
PTCT icon
244
PTC Therapeutics
PTCT
$6.18B
$2.06M 0.15%
40,335
-51,746
-56% -$2.58M
VCYT icon
245
Veracyte
VCYT
$4.45B
$2.05M 0.15%
69,066
-27,566
-29% -$1.05M
IDCC icon
246
InterDigital
IDCC
$6.75B
$2.04M 0.14%
+9,850
New +$1.98M
NBIX icon
247
Neurocrine Biosciences
NBIX
$18.2B
$2.04M 0.14%
18,405
-16,343
-47% -$2.07M
DPZ icon
248
Domino's
DPZ
$11.9B
$2.02M 0.14%
+4,400
New +$1.99M
ABT icon
249
Abbott
ABT
$187B
$2.02M 0.14%
15,207
+7
+0% +$891
RSI icon
250
Rush Street Interactive
RSI
$3.17B
$2.01M 0.14%
187,803
+139,094
+286% +$1.83M
8 9
10
11 12

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

PDT Partners's Q1 2025 Portfolio in Review

As of Q1 2025, PDT Partners held 877 positions worth $1.41B, up 25% from $1.13B the previous quarter. Its ten largest holdings account for 7.6% of the portfolio.

PDT Partners deployed $377M of net new capital in Q1 2025, opening 177 new positions and adding to 293 existing holdings. Its largest new stake was Target: 44,300 shares worth $4.62M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Robinhood, an estimated $6.92M trimmed.

  • PDT Partners's largest Q1 2025 buy was Target: 44,300 shares worth $4.62M.
  • PDT Partners added most to Moderna in Q1 2025, an estimated $7.53M increase.
  • PDT Partners's biggest Q1 2025 reduction was Robinhood, cutting an estimated $6.92M.
  • PDT Partners fully exited Biogen in Q1 2025, selling an estimated $6.03M.
  • PDT Partners's ten largest holdings make up 7.6% of its $1.41B portfolio in Q1 2025.
  • PDT Partners opened 177 new positions and closed 151 in Q1 2025.
  • PDT Partners's portfolio value rose 25% quarter-over-quarter to $1.41B.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.